Over the past 12 months, 9 insiders at TriSalus Life Sciences, Inc. filed 21 open-market SEC Form 4 transactions on TLSI: 7 purchases worth $1.8M and 14 sales worth $134K. Insiders have been net sellers over this period. The most recent filing was on May 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 26 | Gary B. Gordon | BUY | 10.0K | $2.46 | $25K |
| Mar 17, 26 | Mary T SzelaCEO and President | SELL | 15.9K | $3.85 | $61K |
| Mar 16, 26 | Bryan F. CoxChief of Research | SELL | 579 | $4.12 | $2K |
| Mar 16, 26 | Jodi DevlinChief of Clinical Operations | SELL | 273 | $4.12 | $1K |
| Mar 16, 26 | Richard MarshakChief Commercial Officer | SELL | 419 | $4.12 | $2K |
| Mar 16, 26 | Jennifer StevensChief Regulatory Officer | SELL | 774 | $4.12 | $3K |
| Mar 12, 26 | Bryan F. CoxChief of Research | SELL | 1.5K | $4.09 | $6K |
| Mar 12, 26 | Jodi DevlinChief of Clinical Operations | SELL | 1.8K | $4.09 | $7K |
| Mar 12, 26 | Richard MarshakChief Commercial Officer | SELL | 1.6K | $4.09 | $6K |
| Mar 12, 26 | Jennifer StevensChief Regulatory Officer | SELL | 1.6K | $4.09 | $6K |
| Mar 11, 26 | Bryan F. CoxChief of Research | SELL | 1.1K | $4.13 | $5K |
| Mar 11, 26 | Jodi DevlinChief of Clinical Operations | SELL | 1.2K | $4.13 | $5K |
| Mar 11, 26 | Richard MarshakChief Commercial Officer | SELL | 1.4K | $4.13 | $6K |
| Mar 11, 26 | Jennifer StevensChief Regulatory Officer | SELL | 1.2K | $4.13 | $5K |
| Mar 11, 26 | Mary T SzelaCEO and President | SELL | 4.4K | $4.13 | $18K |
| Feb 23, 26 | Gary B. GordonDirector | BUY | 9.8K | $4.10 | $40K |
| Feb 23, 26 | David PatienceChief Financial Officer | BUY | 3.7K | $4.10 | $15K |
| Feb 23, 26 | Michael P StanskyDirector | BUY | 243.9K | $4.10 | $1000K |
| Feb 23, 26 | Mary T SzelaCEO and President | BUY | 30.5K | $4.10 | $125K |
| Feb 23, 26 | William ValleDirector | BUY | 30.5K | $4.10 | $125K |
| May 19, 25 | Bryan F. CoxChief of Research | SELL | 4.8K | $5.18 | $25K |
| May 19, 25 | Jodi DevlinChief of Clinical Operations | SELL | 4.8K | $5.18 | $25K |
| May 19, 25 | Richard MarshakChief Commercial Officer | SELL | 6.6K | $5.18 | $34K |
| May 19, 25 | Jennifer StevensChief Regulatory Officer | SELL | 8.7K | $5.18 | $45K |
| Feb 5, 25 | James Emmett YoungChief Financial Officer | BUY | 6.0K | $5.65 | $34K |
| Jan 30, 25 | Mary T SzelaCEO AND PRESIDENT | BUY | 5.0K | $5.28 | $26K |
| Jan 29, 25 | Mary T SzelaCEO AND PRESIDENT | BUY | 5.0K | $5.03 | $25K |
| Jan 28, 25 | Sean MurphyChief Manuf, Strategy&Bus Dev. | BUY | 15.0K | $5.17 | $78K |
| Jan 28, 25 | Mary T SzelaCEO AND PRESIDENT | BUY | 4.7K | $5.12 | $24K |
| Jan 27, 25 | Sean MurphyChief Manuf, Strategy&Bus Dev. | BUY | 15.0K | $5.31 | $80K |
| Jan 27, 25 | Mary T SzelaCEO AND PRESIDENT | BUY | 4.8K | $5.42 | $26K |
| Jan 27, 25 | James Emmett YoungChief Financial Officer | BUY | 24.0K | $5.40 | $130K |
| Dec 17, 24 | Equity Ab FrankeniusTenPercentOwner | BUY | 63.0K | $3.97 | $250K |
| Dec 10, 24 | Arjun Jj DesaiDirector | SELL | 30.0K | $3.69 | $111K |
| Nov 22, 24 | Mats WahlstromDirector,TenPercentOwner | BUY | 5.0K | $4.55 | $23K |
| Nov 21, 24 | Mats WahlstromDirector,TenPercentOwner | BUY | 8.7K | $4.44 | $39K |
| Nov 20, 24 | Mats WahlstromDirector,TenPercentOwner | BUY | 2.0K | $4.16 | $8K |
| Oct 5, 24 | Bryan F. CoxCHIEF SCIENTIFIC & MANUFACT. | SELL | 314 | $4.44 | $1K |
| Sep 13, 24 | Mary T SzelaCEO AND PRESIDENT | BUY | 6.0K | $5.00 | $30K |
| Sep 12, 24 | Mary T SzelaCEO AND PRESIDENT | BUY | 7.5K | $5.20 | $39K |
| Sep 10, 24 | Mary T SzelaCEO AND PRESIDENT | BUY | 5.0K | $4.97 | $25K |
| Aug 28, 24 | George Kelly MartinDirector | SELL | 9 | $5.50 | $50 |
Over the past 12 months, insiders at TriSalus Life Sciences, Inc. filed 7 open-market purchases worth $1.8M and 14 sales worth $134K on TLSI, which makes them net sellers over the period. The most recent Form 4 was filed on May 15, 26.
The largest recent open-market TLSI insider purchase in our data was $1000K by Michael P Stansky, Director, filed on Feb 23, 26.
9 different insiders at TriSalus Life Sciences, Inc. filed open-market SEC Form 4 transactions on TLSI over the last 12 months.
InsiderTape plots every TLSI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every TriSalus Life Sciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →